CANDIDA ALBICANS

CANDIDA ALBICANS was reported 636 times

CANDIDA ALBICANS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ADMINISTRATION SITE STREAKING 1 0.0909
1 PRODUCT STRENGTH CONFUSION 1 0.0500
2 GALACTOSAEMIA 1 0.0400
3 PUNCTURE SITE INJURY 1 0.0400
4 THALASSAEMIA ALPHA 1 0.0303
5 ANAL POLYP 1 0.0097
6 CELLULITIS OF MALE EXTERNAL GENITAL ORGAN 1 0.0089
7 MULTIPLE CHEMICAL SENSITIVITY 1 0.0075
8 PROSOPAGNOSIA 1 0.0063
9 BLOOD ALDOSTERONE INCREASED 1 0.0057
10 GINGIVAL OPERATION 1 0.0045
11 NECROTISING SOFT TISSUE INFECTION 1 0.0043
12 ELECTROCARDIOGRAM Q WAVE ABNORMAL 1 0.0043
13 POSTPARTUM DEPRESSION 1 0.0039
14 BREAST DISORDER FEMALE 1 0.0039
15 EYELID OPERATION 1 0.0037
16 FACIAL WASTING 1 0.0037
17 PRODUCT IMPURITY 1 0.0036
18 BIOPSY KIDNEY 1 0.0035
19 MUMPS 1 0.0032
20 ALLERGY TO ARTHROPOD BITE 1 0.0031
21 DECREASED VIBRATORY SENSE 1 0.0029
22 HEMIHYPOAESTHESIA 1 0.0028
23 LOCAL REACTION 2 0.0027
24 SCROTAL ABSCESS 1 0.0026
25 LUNG CYST 1 0.0025
26 RAPID EYE MOVEMENTS SLEEP ABNORMAL 1 0.0024
27 TRANSFERRIN SATURATION DECREASED 1 0.0023
28 STUBBORNNESS 1 0.0023
29 SEXUALLY INAPPROPRIATE BEHAVIOUR 1 0.0021
30 BRAIN NEOPLASM BENIGN 1 0.0020
31 LIGAMENT PAIN 1 0.0019
32 SALIVARY GLAND ENLARGEMENT 1 0.0019
33 UTERINE INFECTION 1 0.0019
34 CRYSTAL URINE PRESENT 1 0.0018
35 EYE INFECTION BACTERIAL 1 0.0018
36 COLON INJURY 1 0.0017
37 OXYGEN CONSUMPTION DECREASED 1 0.0017
38 PROLONGED LABOUR 1 0.0016
39 RECTAL FISSURE 1 0.0016
40 MAMMOGRAM ABNORMAL 1 0.0015
41 DEFAECATION DISORDER 1 0.0015
42 MACULAR HOLE 2 0.0015
43 KERATOACANTHOMA 1 0.0015
44 ANGULAR CHEILITIS 1 0.0014
45 PAINFUL DEFAECATION 1 0.0014
46 PEPTIC ULCER HAEMORRHAGE 1 0.0014
47 FALSE NEGATIVE INVESTIGATION RESULT 1 0.0014
48 PUNCTURE SITE HAEMORRHAGE 1 0.0014
49 MYOFASCIAL PAIN SYNDROME 1 0.0014
50 BITE 1 0.0014
51 LIPIDS ABNORMAL 1 0.0014
52 BRAIN CONTUSION 1 0.0014
53 OTITIS MEDIA ACUTE 1 0.0014
54 LEGAL PROBLEM 1 0.0014
55 OBSTRUCTIVE PANCREATITIS 1 0.0013
56 CHONDROCALCINOSIS PYROPHOSPHATE 1 0.0013
57 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 1 0.0013
58 PENILE HAEMORRHAGE 1 0.0012
59 CARDIAC STRESS TEST ABNORMAL 1 0.0012
60 PERIORBITAL PAIN 1 0.0012
61 APTYALISM 1 0.0012
62 CRANIOFACIAL FRACTURE 1 0.0012
63 URGE INCONTINENCE 1 0.0011
64 EMOTIONAL POVERTY 2 0.0011
65 EXPOSURE VIA DIRECT CONTACT 1 0.0011
66 DEVICE SAFETY FEATURE ISSUE 1 0.0010
67 BENIGN BREAST NEOPLASM 1 0.0010
68 METASTASES TO PLEURA 1 0.0010
69 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 1 0.0009
70 NAIL GROWTH ABNORMAL 1 0.0009
71 PERIRECTAL ABSCESS 1 0.0009
72 BILE DUCT CANCER 1 0.0008
73 MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0008
74 GASTROINTESTINAL OBSTRUCTION 2 0.0008
75 GRANULOMATOSIS WITH POLYANGIITIS 1 0.0008
76 JOINT WARMTH 1 0.0008
77 TESTICULAR SWELLING 1 0.0008
78 SINUS ARRHYTHMIA 1 0.0008
79 TONGUE DRY 1 0.0007
80 LIP BLISTER 2 0.0007
81 CLUMSINESS 2 0.0007
82 MENINGITIS BACTERIAL 1 0.0007
83 INVESTIGATION ABNORMAL 1 0.0007
84 COCCYDYNIA 1 0.0007
85 AXILLARY PAIN 1 0.0007
86 EPICONDYLITIS 1 0.0007
87 NEOPLASM SKIN 1 0.0006
88 NASAL ULCER 1 0.0006
89 FOREIGN BODY SENSATION IN EYES 4 0.0006
90 GLYCOSYLATED HAEMOGLOBIN DECREASED 1 0.0006
91 SKULL FRACTURE 1 0.0006
92 PATHOLOGICAL GAMBLING 1 0.0006
93 VEIN RUPTURE 1 0.0006
94 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
95 WRONG PRODUCT ADMINISTERED 4 0.0006
96 MILIARIA 1 0.0006
97 SENSITIVITY OF TEETH 1 0.0006
98 BREAST DISCHARGE 1 0.0006
99 EMBOLIC STROKE 2 0.0006
100 FEAR OF DISEASE 1 0.0006
101 JOINT ARTHROPLASTY 1 0.0006
102 METASTATIC RENAL CELL CARCINOMA 1 0.0005
103 DRUG DOSE TITRATION NOT PERFORMED 1 0.0005
104 INJECTION SITE CELLULITIS 1 0.0005
105 BLOOD IRON INCREASED 1 0.0005
106 LIP DISORDER 1 0.0005
107 BILE DUCT OBSTRUCTION 1 0.0005
108 OESOPHAGEAL DISORDER 2 0.0005
109 SPINAL CORD COMPRESSION 2 0.0005
110 WOUND SECRETION 2 0.0005
111 JOINT CREPITATION 1 0.0005
112 CARDIAC DISCOMFORT 1 0.0005
113 LIPIDS INCREASED 1 0.0005
114 DERMATITIS PSORIASIFORM 1 0.0005
115 POLYCYTHAEMIA 1 0.0005
116 CHAPPED LIPS 2 0.0005
117 SPINAL COLUMN INJURY 1 0.0004
118 PERIARTHRITIS 1 0.0004
119 EYELID DISORDER 1 0.0004
120 HAIR GROWTH ABNORMAL 3 0.0004
121 NEPHROGENIC ANAEMIA 2 0.0004
122 YELLOW SKIN 2 0.0004
123 LACUNAR INFARCTION 1 0.0004
124 SLOW SPEECH 1 0.0004
125 BRONCHITIS CHRONIC 1 0.0004
126 HAEMATOLOGICAL INFECTION 1 0.0004
127 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
128 CARTILAGE INJURY 1 0.0004
129 BLADDER DISORDER 4 0.0004
130 OSTEITIS 1 0.0004
131 METASTASES TO PERITONEUM 1 0.0004
132 URINARY TRACT INFECTION BACTERIAL 1 0.0004
133 ENDODONTIC PROCEDURE 1 0.0004
134 PATHOLOGICAL FRACTURE 2 0.0004
135 RETINAL DISORDER 1 0.0004
136 RADICULOPATHY 1 0.0004
137 AREFLEXIA 1 0.0004
138 WHITE BLOOD CELL DISORDER 1 0.0004
139 WEIGHT BEARING DIFFICULTY 1 0.0004
140 ABNORMAL FAECES 3 0.0004
141 HEART RATE ABNORMAL 2 0.0004
142 EYE PAIN 20 0.0004
143 NECK MASS 1 0.0004
144 CEREBRAL THROMBOSIS 1 0.0004
145 PERONEAL NERVE PALSY 2 0.0004
146 DUODENAL ULCER HAEMORRHAGE 1 0.0003
147 HYPERTONIC BLADDER 1 0.0003
148 VOMITING PROJECTILE 1 0.0003
149 UPPER RESPIRATORY TRACT CONGESTION 1 0.0003
150 CREPITATIONS 1 0.0003
151 BLOOD PRESSURE INADEQUATELY CONTROLLED 2 0.0003
152 CEREBROVASCULAR DISORDER 1 0.0003
153 EMERGENCY CARE 1 0.0003
154 INFUSION SITE PRURITUS 1 0.0003
155 BREAST CANCER RECURRENT 1 0.0003
156 POLYMYALGIA RHEUMATICA 1 0.0003
157 PLASMA CELL MYELOMA RECURRENT 1 0.0003
158 POSTURE ABNORMAL 1 0.0003
159 FACET JOINT SYNDROME 1 0.0003
160 PHARYNGEAL SWELLING 3 0.0003
161 BREAST ENLARGEMENT 1 0.0003
162 SOMNAMBULISM 2 0.0003
163 INJECTION SITE INFECTION 1 0.0003
164 PRODUCT LABEL ISSUE 2 0.0003
165 INTERNATIONAL NORMALISED RATIO ABNORMAL 1 0.0003
166 VIITH NERVE PARALYSIS 1 0.0003
167 GRANULOMA 1 0.0003
168 TACHYPHRENIA 1 0.0003
169 HANGOVER 1 0.0003
170 LOGORRHOEA 1 0.0003
171 LYMPHOCYTE COUNT DECREASED 5 0.0003
172 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
173 ASTHMATIC CRISIS 1 0.0003
174 BLOOD PHOSPHORUS DECREASED 1 0.0003
175 ALCOHOL USE 1 0.0003
176 IMPULSIVE BEHAVIOUR 1 0.0003
177 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
178 FACE INJURY 1 0.0003
179 MICTURITION URGENCY 3 0.0003
180 TENDONITIS 4 0.0003
181 CONCUSSION 2 0.0003
182 SENSATION OF HEAVINESS 1 0.0003
183 EPIGASTRIC DISCOMFORT 1 0.0003
184 ORAL INFECTION 1 0.0003
185 NAIL DISCOLOURATION 1 0.0003
186 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
187 FOREIGN BODY 1 0.0002
188 BLOOD DISORDER 2 0.0002
189 INTRACRANIAL ANEURYSM 1 0.0002
190 ORGAN FAILURE 1 0.0002
191 FUNGAL SKIN INFECTION 1 0.0002
192 ENURESIS 1 0.0002
193 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
194 APPLICATION SITE DISCOLOURATION 1 0.0002
195 GOITRE 1 0.0002
196 SPINAL STENOSIS 1 0.0002
197 LIP OEDEMA 1 0.0002
198 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
199 ABSCESS LIMB 1 0.0002
200 LUNG NEOPLASM 1 0.0002
201 VITAMIN D DECREASED 2 0.0002
202 PRODUCT DISPENSING ISSUE 1 0.0002
203 TONGUE DISCOLOURATION 1 0.0002
204 PULMONARY FUNCTION TEST DECREASED 1 0.0002
205 ONYCHOMYCOSIS 1 0.0002
206 GROIN PAIN 2 0.0002
207 PARONYCHIA 1 0.0002
208 HAEMORRHAGIC ANAEMIA 1 0.0002
209 ANAL INCONTINENCE 2 0.0002
210 URINARY TRACT DISORDER 1 0.0002
211 MULTIPLE SCLEROSIS RELAPSE 15 0.0002
212 INJECTION SITE PAPULE 1 0.0002
213 EAR DISORDER 1 0.0002
214 INCREASED TENDENCY TO BRUISE 2 0.0002
215 FLUSHING 22 0.0002
216 COORDINATION ABNORMAL 3 0.0002
217 GASTRITIS EROSIVE 1 0.0002
218 SKIN REACTION 3 0.0002
219 PHOTOPHOBIA 4 0.0002
220 MULTIPLE SCLEROSIS 10 0.0002
221 PRODUCT SUBSTITUTION ISSUE 12 0.0002
222 APHAGIA 1 0.0002
223 HUMERUS FRACTURE 1 0.0002
224 GUILLAIN-BARRE SYNDROME 1 0.0002
225 HORMONE LEVEL ABNORMAL 1 0.0002
226 VITREOUS FLOATERS 2 0.0002
227 NASAL POLYPS 1 0.0002
228 PANCREATIC DISORDER 1 0.0002
229 URINARY INCONTINENCE 6 0.0002
230 HYPERVOLAEMIA 1 0.0002
231 APPLICATION SITE SWELLING 1 0.0002
232 FLUID INTAKE REDUCED 1 0.0002
233 DERMATITIS EXFOLIATIVE 1 0.0002
234 VEIN DISORDER 1 0.0002
235 DYSPHORIA 1 0.0002
236 VULVOVAGINAL PRURITUS 1 0.0002
237 HIP ARTHROPLASTY 3 0.0002
238 INITIAL INSOMNIA 2 0.0002
239 PRODUCT COLOUR ISSUE 1 0.0002
240 BASAL CELL CARCINOMA 3 0.0002
241 JOINT STIFFNESS 5 0.0002
242 PRODUCT USE COMPLAINT 3 0.0002
243 IMPAIRED WORK ABILITY 4 0.0002
244 PAIN OF SKIN 5 0.0002
245 ANAL ABSCESS 1 0.0002
246 PRODUCT RESIDUE PRESENT 1 0.0002
247 MUSCLE TIGHTNESS 3 0.0002
248 PHARYNGITIS STREPTOCOCCAL 2 0.0002
249 HIP SURGERY 1 0.0002
250 NORMAL NEWBORN 1 0.0002
251 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
252 DEAFNESS UNILATERAL 1 0.0002
253 HYPERKERATOSIS 1 0.0002
254 NERVE INJURY 2 0.0002
255 OCULAR DISCOMFORT 2 0.0002
256 PERIORBITAL SWELLING 1 0.0002
257 DERMATITIS CONTACT 2 0.0002
258 EXERCISE TOLERANCE DECREASED 1 0.0002
259 SKIN WARM 1 0.0002
260 SPINAL PAIN 2 0.0002
261 URINE ODOUR ABNORMAL 1 0.0002
262 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
263 ENERGY INCREASED 1 0.0002
264 CATARACT OPERATION 1 0.0002
265 THIRST 3 0.0002
266 GOUT 3 0.0002
267 TYPE 1 DIABETES MELLITUS 1 0.0002
268 NOCTURIA 2 0.0002
269 SPINAL OPERATION 2 0.0002
270 TENDON RUPTURE 2 0.0002
271 GENERALISED OEDEMA 2 0.0002
272 BLEPHAROSPASM 1 0.0002
273 SCREAMING 1 0.0002
274 PROCTALGIA 1 0.0002
275 HAEMOGLOBIN ABNORMAL 1 0.0002
276 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1 0.0002
277 PRODUCT DOSE OMISSION 10 0.0002
278 HYPOGAMMAGLOBULINAEMIA 1 0.0002
279 SKIN MASS 1 0.0001
280 QUALITY OF LIFE DECREASED 2 0.0001
281 MATERNAL EXPOSURE BEFORE PREGNANCY 1 0.0001
282 BLOOD TESTOSTERONE DECREASED 1 0.0001
283 RIB FRACTURE 3 0.0001
284 ONYCHOCLASIS 1 0.0001
285 DROOLING 1 0.0001
286 LYMPHOEDEMA 1 0.0001
287 BLOOD TEST ABNORMAL 2 0.0001
288 PULMONARY TOXICITY 1 0.0001
289 INTENTIONAL DOSE OMISSION 4 0.0001
290 VISUAL FIELD DEFECT 1 0.0001
291 RASH PUSTULAR 1 0.0001
292 DYSSTASIA 4 0.0001
293 THERAPY CESSATION 7 0.0001
294 SENSITIVE SKIN 1 0.0001
295 LABORATORY TEST ABNORMAL 4 0.0001
296 CEREBRAL DISORDER 1 0.0001
297 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
298 SKIN HAEMORRHAGE 2 0.0001
299 ARTHROPOD BITE 1 0.0001
300 TOOTH DISORDER 3 0.0001
301 FEELING DRUNK 1 0.0001
302 COLON CANCER 2 0.0001
303 HEART RATE IRREGULAR 3 0.0001
304 LACRIMATION INCREASED 4 0.0001
305 TENDON PAIN 1 0.0001
306 BLOOD COUNT ABNORMAL 2 0.0001
307 AORTIC ANEURYSM 1 0.0001
308 BOWEL MOVEMENT IRREGULARITY 1 0.0001
309 DISSOCIATION 1 0.0001
310 MUSCLE TWITCHING 3 0.0001
311 APHTHOUS ULCER 1 0.0001
312 GASTROINTESTINAL INFLAMMATION 1 0.0001
313 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
314 BALANCE DISORDER 11 0.0001
315 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
316 DRUG SCREEN POSITIVE 1 0.0001
317 FURUNCLE 1 0.0001
318 RENAL CYST 1 0.0001
319 GAIT DISTURBANCE 24 0.0001
320 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
321 FRUSTRATION TOLERANCE DECREASED 1 0.0001
322 MUSCLE DISORDER 1 0.0001
323 BLOOD POTASSIUM INCREASED 2 0.0001
324 BACK DISORDER 2 0.0001
325 POST PROCEDURAL INFECTION 1 0.0001
326 ASPHYXIA 1 0.0001
327 POLYURIA 1 0.0001
328 EYE IRRITATION 7 0.0001
329 ESCHERICHIA INFECTION 1 0.0001
330 INFLUENZA LIKE ILLNESS 10 0.0001
331 PHOTOSENSITIVITY REACTION 2 0.0001
332 VIRAL INFECTION 4 0.0001
333 URINARY RETENTION 4 0.0001
334 BLOOD UREA INCREASED 2 0.0001
335 INFUSION SITE ERYTHEMA 1 0.0001
336 ANGER 4 0.0001
337 BLOOD PRESSURE INCREASED 18 0.0001
338 MUSCULOSKELETAL DISCOMFORT 2 0.0001
339 MIGRAINE 11 0.0001
340 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
341 URINE OUTPUT DECREASED 1 0.0001
342 COLD SWEAT 2 0.0001
343 IMMUNOSUPPRESSION 1 0.0001
344 END STAGE RENAL DISEASE 2 0.0001
345 NERVE COMPRESSION 1 0.0001
346 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
347 PERSONALITY CHANGE 1 0.0001
348 EYE SWELLING 4 0.0001
349 RENAL DISORDER 5 0.0001
350 MIDDLE INSOMNIA 2 0.0001
351 SWELLING 10 0.0001
352 HOT FLUSH 8 0.0001
353 PRODUCT PACKAGING ISSUE 1 0.0001
354 NEUROPATHY PERIPHERAL 10 0.0001
355 CONTUSION 10 0.0001
356 PRESCRIBED OVERDOSE 2 0.0001
357 MUSCULOSKELETAL STIFFNESS 9 0.0001
358 AUTOIMMUNE DISORDER 1 0.0001
359 PLASMA CELL MYELOMA 4 0.0001
360 SKIN FISSURES 2 0.0001
361 THERAPY CHANGE 1 0.0001
362 KNEE OPERATION 1 0.0001
363 HOSPICE CARE 1 0.0001
364 LIGAMENT SPRAIN 1 0.0001
365 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
366 EMBEDDED DEVICE 1 0.0001
367 GASTROINTESTINAL DISORDER 9 0.0001
368 HYPOTONIA 1 0.0001
369 SALIVARY HYPERSECRETION 1 0.0001
370 BURNING SENSATION 7 0.0001
371 APHASIA 3 0.0001
372 FULL BLOOD COUNT DECREASED 2 0.0001
373 SLEEP DISORDER 7 0.0001
374 EMPHYSEMA 1 0.0001
375 TOOTH ABSCESS 1 0.0001
376 BLINDNESS 4 0.0001
377 FEELING HOT 6 0.0001
378 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
379 TEMPERATURE INTOLERANCE 1 0.0001
380 VENTRICULAR EXTRASYSTOLES 1 0.0001
381 PULMONARY HYPERTENSION 2 0.0001
382 POLLAKIURIA 4 0.0001
383 KNEE ARTHROPLASTY 2 0.0001
384 SCRATCH 1 0.0001
385 VISION BLURRED 13 0.0001
386 INCONTINENCE 1 0.0001
387 FULL BLOOD COUNT ABNORMAL 1 0.0001
388 RENAL PAIN 1 0.0001
389 MOOD SWINGS 3 0.0001
390 BREAST PAIN 1 0.0001
391 EPISTAXIS 7 0.0001
392 HEREDITARY ANGIOEDEMA 1 0.0001
393 BREAST CANCER METASTATIC 1 0.0001
394 NIGHT SWEATS 3 0.0001
395 MUSCLE SPASMS 17 0.0001
396 ABDOMINAL PAIN UPPER 19 0.0001
397 AMNESIA 6 0.0001
398 SKIN LACERATION 1 0.0001
399 PRODUCT DOSE OMISSION ISSUE 27 0.0001
400 PULMONARY THROMBOSIS 1 0.0001
401 INTENTIONAL PRODUCT MISUSE 8 0.0001
402 PERIPHERAL SWELLING 14 0.0001
403 TOOTH FRACTURE 1 0.0001
404 FUNGAL INFECTION 3 0.0001
405 HYPERTENSIVE CRISIS 1 0.0001
406 NECK PAIN 5 0.0001
407 GLOSSODYNIA 2 0.0001
408 PARAESTHESIA 14 0.0001
409 BLOOD CALCIUM DECREASED 1 0.0001
410 VISUAL IMPAIRMENT 11 0.0001
411 IMPAIRED DRIVING ABILITY 1 0.0001
412 CHOLECYSTECTOMY 1 0.0001
413 INTERNAL HAEMORRHAGE 1 0.0001
414 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
415 HYPOAESTHESIA 13 0.0001
416 CONFUSIONAL STATE 14 0.0001
417 COGNITIVE DISORDER 4 0.0001
418 OCULAR HYPERAEMIA 4 0.0001
419 BLOOD IRON DECREASED 1 0.0001
420 CATARACT 5 0.0001
421 CEREBRAL HAEMORRHAGE 3 0.0001
422 MACULAR DEGENERATION 1 0.0001
423 MUSCLE RIGIDITY 1 0.0001
424 WRIST FRACTURE 1 0.0001
425 LOCALISED INFECTION 2 0.0001
426 CRYING 3 0.0001
427 MENTAL IMPAIRMENT 2 0.0001
428 FIBROMYALGIA 2 0.0001
429 VERTIGO 5 0.0001
430 RESTLESSNESS 3 0.0001
431 ALOPECIA 16 0.0001
432 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
433 HYPERCALCAEMIA 1 0.0001
434 ABNORMAL WEIGHT GAIN 1 0.0001
435 ABASIA 2 0.0001
436 HAIR COLOUR CHANGES 1 0.0001
437 AGEUSIA 2 0.0001
438 INJECTION SITE DISCOLOURATION 1 0.0001
439 SECRETION DISCHARGE 1 0.0001
440 BRAIN OEDEMA 1 0.0001
441 CHRONIC KIDNEY DISEASE 6 0.0001
442 PRODUCT COMPLAINT 2 0.0001
443 MUSCLE ATROPHY 1 0.0001
444 FLUID RETENTION 4 0.0001
445 TREMOR 13 0.0001
446 INTRAOCULAR PRESSURE INCREASED 1 0.0001
447 CONSTIPATION 17 0.0001
448 ILLNESS 8 0.0001
449 SKIN ULCER 2 0.0001
450 RASH GENERALISED 2 0.0001
451 DEAFNESS 2 0.0001
452 SPEECH DISORDER 4 0.0001
453 BEDRIDDEN 1 0.0001
454 IMMUNE SYSTEM DISORDER 1 0.0001
455 TOOTH INFECTION 1 0.0001
456 PULMONARY CONGESTION 1 0.0001
457 HAIR TEXTURE ABNORMAL 1 0.0001
458 PAIN IN EXTREMITY 22 0.0001
459 THROMBOSIS 6 0.0001
460 FEAR 2 0.0001
461 EXTRA DOSE ADMINISTERED 3 0.0001
462 THROAT TIGHTNESS 2 0.0001
463 PRODUCT TASTE ABNORMAL 1 0.0001
464 LIMB INJURY 2 0.0001
465 DRUG TOXICITY 1 0.0001
466 GINGIVAL BLEEDING 1 0.0001
467 PERIPHERAL COLDNESS 1 0.0001
468 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
469 DRUG DOSE OMISSION 12 0.0001
470 ABNORMAL DREAMS 2 0.0001
471 DIVERTICULITIS 2 0.0001
472 ARTHROPATHY 4 0.0001
473 ORAL DISCOMFORT 1 0.0001
474 FEELING COLD 2 0.0001
475 CARPAL TUNNEL SYNDROME 1 0.0001
476 BLISTER 4 0.0001
477 DYSPEPSIA 7 0.0001
478 SKIN EXFOLIATION 6 0.0001
479 FEELING ABNORMAL 17 0.0001
480 BLINDNESS UNILATERAL 1 0.0001
481 LYMPHOPENIA 1 0.0001
482 DEPRESSION 16 0.0001
483 SUBDURAL HAEMATOMA 1 0.0001
484 SEIZURE 8 0.0001
485 MYELODYSPLASTIC SYNDROME 1 0.0001
486 FALL 23 0.0001
487 ANOSMIA 1 0.0001
488 APATHY 1 0.0001
489 PALPITATIONS 8 0.0001
490 SINUSITIS 7 0.0001
491 SURGERY 4 0.0001
492 LIVER DISORDER 3 0.0001
493 ARTHRALGIA 28 0.0001
494 WEIGHT INCREASED 15 0.0001
495 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
496 BLOOD POTASSIUM DECREASED 2 0.0001
497 HEPATIC FAILURE 2 0.0001
498 HYPOAESTHESIA ORAL 1 0.0001
499 JOINT SWELLING 8 0.0001
500 URTICARIA 11 0.0001
501 SUICIDAL IDEATION 6 0.0001
502 MEMORY IMPAIRMENT 9 0.0001
503 DRUG DISPENSING ERROR 1 0.0001
504 PHARYNGEAL OEDEMA 1 0.0001
505 THYROID DISORDER 1 0.0001
506 OROPHARYNGEAL PAIN 6 0.0001
507 LIMB DISCOMFORT 2 0.0001
508 MUSCULOSKELETAL CHEST PAIN 1 0.0001
509 EJECTION FRACTION DECREASED 1 0.0001
510 SWOLLEN TONGUE 2 0.0001
511 HEADACHE 40 0.0001
512 ARTHRITIS 5 0.0001
513 COMA 3 0.0001
514 RASH ERYTHEMATOUS 3 0.0001
515 SCIATICA 1 0.0001
516 ABSCESS 1 0.0001
517 HIP FRACTURE 2 0.0001
518 DRUG INTOLERANCE 6 0.0001
519 METASTASES TO BONE 1 0.0001
520 EYE DISORDER 2 0.0001
521 DIARRHOEA 39 0.0001
522 DRY EYE 3 0.0001
523 INSOMNIA 16 0.0001
524 SKIN DISORDER 2 0.0001
525 AGGRESSION 3 0.0001
526 CHILLS 7 0.0001
527 ABDOMINAL DISCOMFORT 10 0.0001
528 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
529 CANDIDA INFECTION 1 0.0001
530 HEMIPARESIS 1 0.0001
531 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
532 METRORRHAGIA 1 0.0001
533 PAIN 36 0.0001
534 INFLAMMATION 3 0.0001
535 PARANOIA 1 0.0001
536 MULTI-ORGAN FAILURE 1 0.0001
537 NIGHTMARE 2 0.0001
538 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
539 LOCAL SWELLING 1 0.0001
540 DEVICE USE ISSUE 1 0.0001
541 AMENORRHOEA 1 0.0001
542 HEART RATE DECREASED 2 0.0001
543 LYMPHADENOPATHY 2 0.0001
544 HEAD DISCOMFORT 1 0.0001
545 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
546 ISCHAEMIC STROKE 1 0.0001
547 ASTHENIA 21 0.0001
548 MOBILITY DECREASED 4 0.0001
549 ADVERSE DRUG REACTION 5 0.0001
550 DISTURBANCE IN ATTENTION 3 0.0001
551 RASH PRURITIC 3 0.0001
552 TOOTHACHE 1 0.0001
553 OSTEOMYELITIS 1 0.0001
554 RESTLESS LEGS SYNDROME 1 0.0001
555 BONE DISORDER 1 0.0001
556 PANIC ATTACK 2 0.0001
557 ACCIDENTAL OVERDOSE 2 0.0001
558 ANAPHYLACTIC REACTION 3 0.0001
559 BLOOD GLUCOSE ABNORMAL 1 0.0001
560 DIZZINESS 27 0.0001
561 CONJUNCTIVITIS 1 0.0001
562 DYSGEUSIA 4 0.0001
563 HEPATIC STEATOSIS 1 0.0001
564 THINKING ABNORMAL 1 0.0001
565 HALLUCINATION 4 0.0001
566 BLOOD SODIUM DECREASED 1 0.0001
567 FOOT FRACTURE 1 0.0001
568 BLOOD URINE PRESENT 1 0.0001
569 MUSCULOSKELETAL DISORDER 1 0.0001
570 FEELING JITTERY 1 0.0001
571 MALAISE 23 0.0001
572 SLEEP APNOEA SYNDROME 1 0.0001
573 LETHARGY 3 0.0001
574 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
575 PRURITUS 20 0.0001
576 GLAUCOMA 1 0.0001
577 ERUCTATION 1 0.0001
578 DYSTONIA 1 0.0001
579 COVID-19 9 0.0001
580 NASAL CONGESTION 3 0.0001
581 UPPER LIMB FRACTURE 1 0.0001
582 WEIGHT DECREASED 14 0.0001
583 INJECTION SITE BRUISING 4 0.0001
584 FATIGUE 39 0.0001
585 SPINAL FRACTURE 1 0.0000
586 PRODUCT PHYSICAL ISSUE 1 0.0000
587 STOMATITIS 3 0.0000
588 PSORIATIC ARTHROPATHY 2 0.0000
589 DISCOMFORT 3 0.0000
590 INJURY ASSOCIATED WITH DEVICE 1 0.0000
591 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
592 CHEST DISCOMFORT 5 0.0000
593 OSTEOPOROSIS 2 0.0000
594 INJECTION SITE WARMTH 1 0.0000
595 TOOTH LOSS 1 0.0000
596 HAEMORRHAGE 5 0.0000
597 BACK PAIN 11 0.0000
598 OSTEOARTHRITIS 2 0.0000
599 EATING DISORDER 1 0.0000
600 RETCHING 1 0.0000
601 RECTAL HAEMORRHAGE 2 0.0000
602 HYPOACUSIS 2 0.0000
603 POOR QUALITY SLEEP 1 0.0000
604 PNEUMONIA 15 0.0000
605 PRURITUS GENERALISED 1 0.0000
606 DEEP VEIN THROMBOSIS 3 0.0000
607 MENTAL DISORDER 2 0.0000
608 PRODUCT PRESCRIBING ISSUE 1 0.0000
609 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
610 HOSPITALISATION 7 0.0000
611 MELAENA 1 0.0000
612 APPLICATION SITE PAIN 1 0.0000
613 BLOOD PRESSURE DECREASED 3 0.0000
614 VOMITING 21 0.0000
615 THROAT IRRITATION 2 0.0000
616 CHROMATURIA 1 0.0000
617 MUSCULAR WEAKNESS 5 0.0000
618 ERYTHEMA 9 0.0000
619 SKIN IRRITATION 2 0.0000
620 INJECTION SITE REACTION 3 0.0000
621 TINNITUS 2 0.0000
622 SHOCK 1 0.0000
623 PERICARDIAL EFFUSION 1 0.0000
624 CHEST PAIN 8 0.0000
625 HYPERSENSITIVITY 8 0.0000
626 DECREASED APPETITE 10 0.0000
627 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
628 PRODUCT USE ISSUE 8 0.0000
629 DYSPHAGIA 4 0.0000
630 DISEASE RECURRENCE 2 0.0000
631 HEPATIC CANCER 1 0.0000
632 INTERSTITIAL LUNG DISEASE 2 0.0000
633 MYALGIA 7 0.0000
634 URINARY TRACT INFECTION 7 0.0000
635 AGITATION 3 0.0000
636 LUNG DISORDER 2 0.0000
637 INJECTION SITE URTICARIA 1 0.0000
638 NAUSEA 32 0.0000
639 OSTEONECROSIS OF JAW 1 0.0000
640 HEART RATE INCREASED 4 0.0000
641 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
642 MYOCARDIAL INFARCTION 7 0.0000
643 CELLULITIS 2 0.0000
644 ACNE 3 0.0000
645 ABDOMINAL PAIN LOWER 1 0.0000
646 CONDITION AGGRAVATED 12 0.0000
647 HEPATITIS 1 0.0000
648 LOSS OF CONSCIOUSNESS 5 0.0000
649 DIPLOPIA 1 0.0000
650 RESPIRATORY TRACT INFECTION 1 0.0000
651 PSORIASIS 5 0.0000
652 NERVOUSNESS 2 0.0000
653 MUSCULOSKELETAL PAIN 2 0.0000
654 APPLICATION SITE ERYTHEMA 1 0.0000
655 DEPRESSED MOOD 2 0.0000
656 EAR INFECTION 1 0.0000
657 DEHYDRATION 5 0.0000
658 BREAST CANCER FEMALE 1 0.0000
659 CARDIAC FAILURE CONGESTIVE 3 0.0000
660 BLOOD GLUCOSE INCREASED 7 0.0000
661 DYSPNOEA 21 0.0000
662 FREQUENT BOWEL MOVEMENTS 1 0.0000
663 DRY MOUTH 3 0.0000
664 OEDEMA 2 0.0000
665 PRODUCT QUALITY ISSUE 5 0.0000
666 RESPIRATORY DISTRESS 1 0.0000
667 PROCEDURAL PAIN 1 0.0000
668 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
669 INFLUENZA 4 0.0000
670 HAEMOPTYSIS 1 0.0000
671 DEMENTIA 1 0.0000
672 WOUND 1 0.0000
673 PAIN IN JAW 1 0.0000
674 HYPERSOMNIA 1 0.0000
675 SOMNOLENCE 7 0.0000
676 PANCREATIC CARCINOMA 1 0.0000
677 RASH 15 0.0000
678 NEEDLE ISSUE 1 0.0000
679 DYSPHONIA 2 0.0000
680 BONE PAIN 2 0.0000
681 ACUTE MYOCARDIAL INFARCTION 1 0.0000
682 SUICIDE ATTEMPT 2 0.0000
683 ILL-DEFINED DISORDER 2 0.0000
684 PLEURAL EFFUSION 2 0.0000
685 EPILEPSY 1 0.0000
686 ACUTE KIDNEY INJURY 5 0.0000
687 DRUG ADMINISTRATION ERROR 1 0.0000
688 ADVERSE EVENT 3 0.0000
689 NASOPHARYNGITIS 6 0.0000
690 EMOTIONAL DISORDER 1 0.0000
691 FEMUR FRACTURE 1 0.0000
692 NERVOUS SYSTEM DISORDER 1 0.0000
693 BONE DENSITY DECREASED 1 0.0000
694 ANXIETY 9 0.0000
695 CYSTITIS 1 0.0000
696 HYPOTHYROIDISM 1 0.0000
697 MOVEMENT DISORDER 1 0.0000
698 RHINORRHOEA 2 0.0000
699 ATRIAL FIBRILLATION 3 0.0000
700 SWELLING FACE 2 0.0000
701 IMPAIRED HEALING 1 0.0000
702 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
703 RENAL FAILURE 4 0.0000
704 VISUAL ACUITY REDUCED 1 0.0000
705 EXPIRED PRODUCT ADMINISTERED 1 0.0000
706 LIP SWELLING 1 0.0000
707 NEOPLASM MALIGNANT 2 0.0000
708 GAIT INABILITY 1 0.0000
709 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
710 CEREBROVASCULAR ACCIDENT 5 0.0000
711 HEPATIC ENZYME INCREASED 2 0.0000
712 HAEMATURIA 1 0.0000
713 GASTRIC DISORDER 1 0.0000
714 DELIRIUM 1 0.0000
715 HYPERKALAEMIA 1 0.0000
716 HYPOXIA 1 0.0000
717 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
718 PLATELET COUNT DECREASED 3 0.0000
719 THERAPY INTERRUPTED 2 0.0000
720 INFECTION 4 0.0000
721 HYPERGLYCAEMIA 1 0.0000
722 UNDERDOSE 2 0.0000
723 DYSURIA 1 0.0000
724 INJECTION SITE MASS 1 0.0000
725 BRONCHITIS 2 0.0000
726 SEPSIS 3 0.0000
727 DYSARTHRIA 1 0.0000
728 DYSPNOEA EXERTIONAL 1 0.0000
729 ASTHMA 3 0.0000
730 INTESTINAL OBSTRUCTION 1 0.0000
731 COLITIS 1 0.0000
732 PYREXIA 9 0.0000
733 DEATH 22 0.0000
734 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
735 ABNORMAL BEHAVIOUR 1 0.0000
736 DISORIENTATION 1 0.0000
737 OEDEMA PERIPHERAL 3 0.0000
738 DYSKINESIA 1 0.0000
739 NEUTROPHIL COUNT DECREASED 1 0.0000
740 LUNG NEOPLASM MALIGNANT 1 0.0000
741 PRODUCT USE IN UNAPPROVED INDICATION 6 0.0000
742 INJECTION SITE ERYTHEMA 3 0.0000
743 RHABDOMYOLYSIS 1 0.0000
744 ROAD TRAFFIC ACCIDENT 1 0.0000
745 WITHDRAWAL SYNDROME 1 0.0000
746 HYPERTENSION 5 0.0000
747 RENAL FAILURE ACUTE 1 0.0000
748 HYPERHIDROSIS 3 0.0000
749 DEVICE DISLOCATION 1 0.0000
750 SEPTIC SHOCK 1 0.0000
751 ANGIOEDEMA 1 0.0000
752 TACHYCARDIA 2 0.0000
753 DRY SKIN 3 0.0000
754 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
755 COLITIS ULCERATIVE 1 0.0000
756 DEVICE ISSUE 2 0.0000
757 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
758 SKIN DISCOLOURATION 1 0.0000
759 HYPOKALAEMIA 1 0.0000
760 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
761 COUGH 6 0.0000
762 CARDIAC DISORDER 2 0.0000
763 ANAEMIA 4 0.0000
764 COLORECTAL CANCER 1 0.0000
765 PRODUCTIVE COUGH 1 0.0000
766 BLOOD GLUCOSE DECREASED 1 0.0000
767 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
768 HYPOTENSION 4 0.0000
769 OFF LABEL USE 17 0.0000
770 PANCREATITIS 1 0.0000
771 BRADYCARDIA 1 0.0000
772 DRUG EFFECT DECREASED 1 0.0000
773 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
774 TREATMENT NONCOMPLIANCE 1 0.0000
775 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
776 HAEMATOCHEZIA 1 0.0000
777 OXYGEN SATURATION DECREASED 1 0.0000
778 FLATULENCE 1 0.0000
779 RHEUMATOID ARTHRITIS 2 0.0000
780 HERPES ZOSTER 1 0.0000
781 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
782 ABDOMINAL PAIN 4 0.0000
783 DISEASE PROGRESSION 2 0.0000
784 WHEEZING 1 0.0000
785 IRRITABILITY 1 0.0000
786 THERAPEUTIC RESPONSE DECREASED 1 0.0000
787 DRUG INEFFECTIVE 20 0.0000
788 INFUSION RELATED REACTION 1 0.0000
789 INJECTION SITE PRURITUS 1 0.0000
790 DEVICE MALFUNCTION 1 0.0000
791 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
792 SKIN BURNING SENSATION 1 0.0000
793 OVERDOSE 3 0.0000
794 RESPIRATORY FAILURE 1 0.0000
795 UNEVALUABLE EVENT 1 0.0000
796 DIABETES MELLITUS 1 0.0000
797 INJECTION SITE SWELLING 1 0.0000
798 DRUG INTERACTION 2 0.0000
799 INJECTION SITE HAEMORRHAGE 1 0.0000
800 CARDIAC FAILURE 1 0.0000
801 PROSTATE CANCER 1 0.0000
802 CARDIAC ARREST 1 0.0000
803 TREATMENT FAILURE 1 0.0000
804 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
805 DRUG WITHDRAWAL SYNDROME 1 0.0000
806 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
807 NO ADVERSE EVENT 2 0.0000
808 BREAST CANCER 1 0.0000
809 PULMONARY EMBOLISM 1 0.0000
810 SYNCOPE 1 0.0000
811 ABDOMINAL DISTENSION 1 0.0000
812 INCORRECT DOSE ADMINISTERED 2 0.0000
813 NEUTROPENIA 1 0.0000
814 INJECTION SITE PAIN 2 0.0000
815 TOXICITY TO VARIOUS AGENTS 1 0.0000
816 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000